{"id":"https://openalex.org/A5159042188","orcid":null,"observed_orcids":[],"display_name":"Ryuga Kato","raw_author_names":["Ryuga Kato"],"full_name":"Ryuga Kato","works_count":1,"cited_by_count":0,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":0,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5159042188","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I4405255255","ror":"https://ror.org/02spwfy20","display_name":"Nagoya Tokushukai General Hospital","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405255255"]},"years":[2026]}],"last_known_institutions":[{"id":"https://openalex.org/I4405255255","ror":"https://ror.org/02spwfy20","display_name":"Nagoya Tokushukai General Hospital","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405255255"]}],"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","count":1,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","count":1,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","value":1.2e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","value":4.5e-06,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","value":2.1e-06,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","score":0.7271000146865845},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.6611999869346619},{"id":"143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","score":0.5325000286102295},{"id":"167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","score":0.3192000091075897},{"id":"10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","score":0.26570001244544983}],"counts_by_year":[{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":0}],"display_name_alternatives":["Ryuga Kato"],"block_key":"r kato","works_api_url":"https://api.openalex.org/works?filter=author.id:A5159042188","updated_date":"2026-10-28T12:34:19","created_date":"2026-10-20T00:00:00"}